Search results
Results From The WOW.Com Content Network
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [1]
DIC India Limited NSE: DGCONTENT: Digicontent Limited NSE: DIGISPICE: DiGiSPICE Technologies Limited NSE: DIGJAMLTD: Digjam Limited NSE: DNAMEDIA: Diligent Media Corporation Limited NSE: DBL: Dilip Buildcon Limited NSE: DISHTV: Dish TV India Limited NSE: DCAL: Dishman Carbogen Amcis Limited NSE: DIVISLAB: Divi's Laboratories Limited NSE: DIXON
Sanofi-Aventis was formed in 2004, when Sanofi-Synthélabo acquired Aventis. In early 2004, Sanofi-Synthélabo made a hostile takeover bid for Aventis worth €47.8 billion. Initially, Aventis rejected the bid because it felt that the bid offered inferior value based on the company's share value, and the board of Aventis went so far as to enact ...
Although the latest news from the laboratory was mixed for pharmaceutical company Sanofi (NASDAQ: SNY) on Tuesday, investors gave the company the benefit of the doubt. They bid the share price up ...
Need help? Call us! 800-290-4726 Login / Join. Mail
The National Stock Exchange building in the Bandra Kurla Complex in Mumbai Performance of the NIFTY 50 index between 2000 and 2024 Performance of the NIFTY Next 50 index between 2000 and 2024. National Stock Exchange of India Limited (NSE) is one of the leading stock exchanges in India, based in Mumbai. NSE is under the ownership of various ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
(Reuters) -Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion) or more, Bloomberg News reported ...